Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Retsevmo as monotherapy is indicated for the treatment of adults with: advanced RET fusion-positive non-small cell lung cancer (NSCLC) not previously treated with a RET inhibitor; advanced RET fusion-positive thyroid cancer who require systemic therapy following prior treatment with sorafenib and/or lenvatinib.
Retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced RET-mutant medullary thyroid cancer (MTC).

Retsevmo Indications/Uses

selpercatinib

Manufacturer:

Eli Lilly

Distributor:

Zuellig